DocGo (DCGO) Financials

$1.18 -0.08 (-6.35%)

Closing price 10/24/2025 04:00 PM Eastern

Extended Trading

$1.20 +0.02 (+1.27%)

As of 10/24/2025 07:49 PM Eastern

Annual Income Statements for DocGo

This table shows DocGo's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	35	6.86	20
Consolidated Net Income / (Loss)	31	10	13
Net Income / (Loss) Continuing Operations	31	10	13
Total Pre-Tax Income	23	16	28
Total Operating Income	22	15	29
Total Gross Profit	155	195	214
Total Revenue	441	624	617
Operating Revenue	441	624	617
Total Cost of Revenue	286	429	403
Operating Cost of Revenue	286	429	403
Total Operating Expenses	133	180	185
Selling, General & Admin Expense	103	137	139
Marketing Expense	4.76	2.80	1.51
Research & Development Expense	5.38	11	12
Depreciation Expense	11	16	16
Other Special Charges / (Income)	8.78	13	17
Total Other Income / (Expense), net	0.95	1.24	-0.94
Interest & Investment Income	0.77	1.34	-2.25
Other Income / (Expense), net	0.18	-0.10	1.31
Income Tax Expense	-7.96	6.24	14
Net Income / (Loss) Attributable to Noncontrolling Interest	-3.84	3.19	-6.63
Basic Earnings per Share	$0.34	$0.07	$0.20
Weighted Average Basic Shares Outstanding	101.23M	103.51M	102.40M
Diluted Earnings per Share	$0.34	$0.06	$0.18
Weighted Average Diluted Shares Outstanding	102.98M	105.62M	109.42M
Weighted Average Basic & Diluted Shares Outstanding	102.51M	104.17M	101.98M

This table shows DocGo's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	3.15	8.06	-3.47	-2.01	4.76	7.57	11	6.53	5.50	-3.26
Consolidated Net Income / (Loss)	2.47	7.15	-3.92	1.34	4.63	7.99	11	5.86	4.55	-7.65
Net Income / (Loss) Continuing Operations	2.47	7.15	-3.92	1.34	4.63	7.99	11	5.86	4.55	-7.65
Total Pre-Tax Income	2.87	-1.98	-6.05	0.99	9.16	12	16	9.57	9.03	-6.58
Total Operating Income	4.20	0.08	-6.90	1.58	8.71	12	16	10	10	-7.47
Total Gross Profit	33	42	113	125	55	-98	67	165	139	-157
Total Revenue	104	109	113	125	187	199	192	165	139	121
Operating Revenue	104	109	113	125	187	199	192	165	139	121
Total Cost of Revenue	71	66	0.00	0.00	132	297	125	0.00	0.00	278
Total Operating Expenses	29	42	120	124	46	-110	52	155	129	-150
Selling, General & Admin Expense	22	33	29	31	34	44	40	35	29	35
Marketing Expense	0.09	2.41	0.31	0.69	1.61	0.20	0.34	0.39	0.38	0.40
Research & Development Expense	1.37	1.72	1.86	2.57	3.24	3.19	2.39	2.37	3.15	3.69
Depreciation Expense	3.01	3.31	3.65	3.83	4.34	4.62	4.18	4.20	4.18	3.32
Other Special Charges / (Income)	2.20	2.17	3.64	2.40	3.55	3.49	4.31	4.01	3.30	5.53
Total Other Income / (Expense), net	-1.33	-2.06	0.85	-0.59	0.45	0.52	-0.15	-0.58	-1.10	0.90
Interest & Investment Income	0.09	-	-0.12	0.43	0.25	0.77	-0.08	-0.58	-0.59	-1.00
Other Income / (Expense), net	-1.76	-2.52	0.16	-1.02	0.20	0.56	0.30	-0.00	-0.52	1.53
Income Tax Expense	0.40	-9.13	-2.13	-0.36	4.53	4.20	5.12	3.71	4.49	1.07
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.69	-0.92	-0.45	3.35	-0.13	0.42	-0.62	-0.67	-0.95	-4.38
Basic Earnings per Share	$0.03	$0.07	($0.03)	($0.02)	$0.05	$0.07	$0.11	$0.06	$0.05	($0.02)
Weighted Average Basic Shares Outstanding	98.96M	101.23M	102.58M	103.59M	103.87M	103.51M	103.82M	101.84M	102.07M	102.40M
Diluted Earnings per Share	$0.03	$0.11	($0.03)	($0.02)	$0.05	$0.06	$0.10	$0.06	$0.05	($0.03)
Weighted Average Diluted Shares Outstanding	107.40M	102.98M	102.58M	103.59M	104.99M	105.62M	108.51M	106.32M	106.29M	109.42M
Weighted Average Basic & Diluted Shares Outstanding	102.83M	102.51M	103.47M	103.79M	103.90M	104.17M	101.57M	102.32M	102.05M	101.98M

This table details how cash moves in and out of DocGo's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	-15	-92	35
Net Cash From Operating Activities	29	-64	70
Net Cash From Continuing Operating Activities	29	-64	70
Net Income / (Loss) Continuing Operations	31	10	13
Consolidated Net Income / (Loss)	31	10	13
Depreciation Expense	4.11	4.83	5.61
Amortization Expense	6.45	12	10
Non-Cash Adjustments To Reconcile Net Income	11	26	28
Changes in Operating Assets and Liabilities, net	-23	-117	14
Net Cash From Investing Activities	-38	-30	-11
Net Cash From Continuing Investing Activities	-38	-30	-11
Purchase of Property, Plant & Equipment	-3.20	-7.58	-3.83
Acquisitions	-35	-23	-2.31
Purchase of Investments	-	-	-5.00
Sale of Property, Plant & Equipment	0.00	0.75	0.27
Net Cash From Financing Activities	-6.18	1.12	-24
Net Cash From Continuing Financing Activities	-6.18	1.12	-24
Repayment of Debt	-3.94	-4.30	-40
Repurchase of Common Equity	-3.75	0.00	-14
Payment of Dividends	0.00	0.00	-3.14
Issuance of Debt	0.00	25	45
Issuance of Common Equity	2.06	0.00	0.00
Other Financing Activities, net	-0.55	-20	-12
Cash Interest Paid	0.76	0.85	2.14
Cash Income Taxes Paid	1.51	4.25	7.25

This table details how cash moves in and out of DocGo's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	-29	-15	-37	-3.76	-57	4.96	-13	27	23	-1.24
Net Cash From Operating Activities	7.42	-8.74	-23	11	-46	-5.92	-11	37	31	13
Net Cash From Continuing Operating Activities	7.42	-8.74	-23	11	-46	-5.92	-11	37	31	13
Net Income / (Loss) Continuing Operations	2.47	7.15	-3.92	1.34	4.63	7.99	11	5.86	4.55	-7.65
Consolidated Net Income / (Loss)	2.47	7.15	-3.92	1.34	4.63	7.99	11	5.86	4.55	-7.65
Depreciation Expense	1.15	1.52	1.48	1.59	1.63	0.13	1.43	1.48	1.37	1.32
Amortization Expense	1.86	1.79	2.17	2.24	2.71	4.48	2.75	2.73	2.80	2.00
Non-Cash Adjustments To Reconcile Net Income	3.72	6.23	6.79	6.42	2.17	10	5.38	4.10	4.36	14
Changes in Operating Assets and Liabilities, net	-1.78	-25	-30	-0.90	-57	-29	-31	23	18	3.25
Net Cash From Investing Activities	-36	-0.65	-1.69	-24	-1.50	-2.96	-1.70	-2.09	-1.51	-5.57
Net Cash From Continuing Investing Activities	-36	-0.65	-1.69	-24	-1.50	-2.96	-1.70	-2.09	-1.51	-5.57
Purchase of Property, Plant & Equipment	-1.05	-1.20	-1.98	-1.58	-0.80	-3.22	-0.95	-1.20	-0.79	-0.89
Acquisitions	-35	0.55	0.17	-22	-0.70	-0.21	-0.77	-0.94	-0.82	0.23
Sale of Property, Plant & Equipment	-	0.00	0.12	0.16	-0.00	0.47	0.03	0.06	0.10	0.10
Net Cash From Financing Activities	-0.44	-6.87	-12	8.76	-8.67	13	-0.88	-8.07	-7.35	-7.86
Net Cash From Continuing Financing Activities	-0.44	-6.87	-12	8.76	-8.67	13	-0.88	-8.07	-7.35	-7.86
Repayment of Debt	-2.44	-1.20	-0.13	-1.63	-1.06	-1.47	-41	-1.07	-1.09	3.09
Repurchase of Common Equity	0.00	-3.23	0.00	-	-	-	-4.88	-4.90	-1.30	-2.68
Payment of Dividends	-	-	-	-	-	-	-	-	-1.85	-1.04
Other Financing Activities, net	2.01	-1.43	-12	10	-7.60	-11	-0.02	-1.84	-3.11	-7.22
Cash Interest Paid	0.41	0.22	0.03	0.35	0.19	0.28	0.63	0.65	0.79	0.07
Cash Income Taxes Paid	0.16	0.59	0.04	4.18	-	0.03	0.56	0.81	5.17	0.71

This table presents DocGo's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Total Assets	393	490	456
Total Current Assets	271	339	304
Cash & Equivalents	157	59	89
Accounts Receivable	103	262	211
Prepaid Expenses	6.27	17	4.34
Plant, Property, & Equipment, net	21	17	15
Total Noncurrent Assets	101	135	136
Noncurrent Note & Lease Receivables	9.04	12	15
Goodwill	39	48	47
Intangible Assets	23	38	26
Noncurrent Deferred & Refundable Income Taxes	9.96	12	8.42
Other Noncurrent Operating Assets	19	26	39
Total Liabilities & Shareholders' Equity	393	490	456
Total Liabilities	114	185	140
Total Current Liabilities	100	170	122
Short-Term Debt	0.66	25	30
Accounts Payable	22	20	28
Accrued Expenses	32	91	50
Other Current Liabilities	42	34	14
Total Noncurrent Liabilities	14	15	19
Long-Term Debt	1.24	0.04	0.01
Other Noncurrent Operating Liabilities	13	15	19
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	279	305	315
Total Preferred & Common Equity	273	301	321
Total Common Equity	273	301	321
Common Stock	301	321	321
Retained Earnings	-29	-21	-1.40
Accumulated Other Comprehensive Income / (Loss)	0.74	1.48	1.22
Noncontrolling Interest	5.70	4.38	-5.74

This table presents DocGo's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024
Total Assets	356	408	390	420	491	488	494
Total Current Assets	252	258	234	267	335	329	328
Cash & Equivalents	170	120	109	53	41	66	89
Accounts Receivable	80	132	118	207	283	258	234
Prepaid Expenses	2.39	6.74	6.79	6.90	11	5.14	5.15
Plant, Property, & Equipment, net	18	22	22	22	16	16	15
Total Noncurrent Assets	86	127	134	131	139	143	150
Long-Term Investments	0.71	0.48	0.39	0.45	0.47	0.55	0.63
Noncurrent Note & Lease Receivables	9.42	9.17	8.96	8.57	13	14	15
Goodwill	35	48	48	48	47	48	48
Intangible Assets	21	39	38	39	37	36	35
Noncurrent Deferred & Refundable Income Taxes	-	-	11	8.91	12	14	17
Other Noncurrent Operating Assets	21	31	27	27	29	31	35
Total Liabilities & Shareholders' Equity	356	408	390	420	491	488	494
Total Liabilities	85	124	106	128	176	170	169
Total Current Liabilities	71	109	92	113	160	154	150
Short-Term Debt	5.71	0.65	19	14	30	30	30
Accounts Payable	22	19	6.69	8.95	26	31	35
Accrued Expenses	39	31	35	59	70	63	60
Other Current Liabilities	4.92	32	32	32	34	30	25
Total Noncurrent Liabilities	14	15	15	15	15	16	19
Long-Term Debt	1.46	1.27	1.58	2.04	0.03	0.03	0.02
Other Noncurrent Operating Liabilities	12	13	13	13	15	16	19
Commitments & Contingencies	0.00	26	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	271	284	284	292	315	318	325
Total Preferred & Common Equity	264	279	280	288	311	315	325
Total Common Equity	264	279	280	288	311	315	325
Common Stock	302	310	312	316	320	317	321
Retained Earnings	-37	-32	-34	-29	-10	-3.64	1.86
Accumulated Other Comprehensive Income / (Loss)	-0.28	0.98	1.39	0.81	1.34	1.38	2.31
Noncontrolling Interest	6.61	5.24	4.09	3.95	3.75	2.83	-0.31

This table displays calculated financial ratios and metrics derived from DocGo's official financial filings.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-
Revenue Growth	38.21%	41.72%	-1.24%
EBITDA Growth	18.23%	-3.66%	46.19%
EBIT Growth	7.46%	-32.07%	100.60%
NOPAT Growth	97.99%	-68.48%	48.77%
Net Income Growth	60.29%	-67.32%	32.96%
EPS Growth	36.00%	-82.35%	200.00%
Operating Cash Flow Growth	1,582.47%	-322.45%	209.52%
Free Cash Flow Firm Growth	-1,750.53%	-242.02%	120.76%
Invested Capital Growth	132.49%	120.48%	-5.54%
Revenue Q/Q Growth	-2.70%	16.95%	-11.28%
EBITDA Q/Q Growth	-39.53%	71.22%	-29.79%
EBIT Q/Q Growth	-51.15%	367.04%	-37.73%
NOPAT Q/Q Growth	-18.71%	-38.21%	-53.68%
Net Income Q/Q Growth	-29.92%	9.18%	-53.93%
EPS Q/Q Growth	-98.18%	-45.45%	-33.33%
Operating Cash Flow Q/Q Growth	0.22%	4.20%	36.49%
Free Cash Flow Firm Q/Q Growth	0.00%	-5.77%	52.60%
Invested Capital Q/Q Growth	14.13%	6.71%	-3.36%
Profitability Metrics	-	-	-
Gross Margin	35.12%	31.30%	34.64%
EBITDA Margin	7.39%	5.03%	7.44%
Operating Margin	4.96%	2.41%	4.65%
EBIT Margin	5.00%	2.40%	4.86%
Profit (Net Income) Margin	6.98%	1.61%	2.17%
Tax Burden Percent	134.95%	61.67%	48.15%
Interest Burden Percent	103.51%	108.97%	92.51%
Effective Tax Rate	-34.95%	38.33%	51.85%
Return on Invested Capital (ROIC)	33.52%	4.71%	5.24%
ROIC Less NNEP Spread (ROIC-NNEP)	32.75%	3.91%	6.21%
Return on Net Nonoperating Assets (RNNOA)	-21.37%	-1.27%	-0.94%
Return on Equity (ROE)	12.15%	3.44%	4.31%
Cash Return on Invested Capital (CROIC)	-46.17%	-70.47%	10.94%
Operating Return on Assets (OROA)	6.26%	3.38%	6.34%
Return on Assets (ROA)	8.75%	2.27%	2.82%
Return on Common Equity (ROCE)	11.84%	3.38%	4.32%
Return on Equity Simple (ROE_SIMPLE)	11.25%	3.34%	4.16%
Net Operating Profit after Tax (NOPAT)	29	9.28	14
NOPAT Margin	6.69%	1.49%	2.24%
Net Nonoperating Expense Percent (NNEP)	0.78%	0.80%	-0.97%
Return On Investment Capital (ROIC_SIMPLE)	10.49%	2.81%	4.00%
Cost of Revenue to Revenue	64.88%	68.70%	65.36%
SG&A Expenses to Revenue	23.47%	21.97%	22.51%
R&D to Revenue	1.22%	1.74%	1.88%
Operating Expenses to Revenue	30.17%	28.89%	29.99%
Earnings before Interest and Taxes (EBIT)	22	15	30
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	33	31	46
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	2.66	1.93	1.35
Price to Tangible Book Value (P/TBV)	3.44	2.69	1.75
Price to Revenue (P/Rev)	1.65	0.93	0.70
Price to Earnings (P/E)	21.02	84.68	21.64
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	4.76%	1.18%	4.62%
Enterprise Value to Invested Capital (EV/IC)	4.69	2.03	1.44
Enterprise Value to Revenue (EV/Rev)	1.31	0.88	0.60
Enterprise Value to EBITDA (EV/EBITDA)	17.70	17.55	8.02
Enterprise Value to EBIT (EV/EBIT)	26.20	36.85	12.26
Enterprise Value to NOPAT (EV/NOPAT)	19.57	59.34	26.62
Enterprise Value to Operating Cash Flow (EV/OCF)	19.97	0.00	5.23
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	12.76
Leverage & Solvency	-	-	-
Debt to Equity	0.01	0.08	0.10
Long-Term Debt to Equity	0.00	0.00	0.00
Financial Leverage	-0.65	-0.33	-0.15
Leverage Ratio	1.39	1.51	1.53
Compound Leverage Factor	1.44	1.65	1.41
Debt to Total Capital	0.68%	7.59%	8.70%
Short-Term Debt to Total Capital	0.24%	7.58%	8.69%
Long-Term Debt to Total Capital	0.44%	0.01%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	2.03%	1.33%	-1.66%
Common Equity to Total Capital	97.29%	91.08%	92.97%
Debt to EBITDA	0.06	0.80	0.65
Net Debt to EBITDA	-4.79	-1.09	-1.29
Long-Term Debt to EBITDA	0.04	0.00	0.00
Debt to NOPAT	0.06	2.70	2.17
Net Debt to NOPAT	-5.30	-3.69	-4.29
Long-Term Debt to NOPAT	0.04	0.00	0.00
Altman Z-Score	5.54	3.61	3.90
Noncontrolling Interest Sharing Ratio	2.60%	1.72%	-0.22%
Liquidity Ratios	-	-	-
Current Ratio	2.71	1.99	2.50
Quick Ratio	2.60	1.89	2.46
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-41	-139	29
Operating Cash Flow to CapEx	903.53%	-939.26%	1,975.92%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00
Efficiency Ratios	-	-	-
Asset Turnover	1.25	1.41	1.30
Accounts Receivable Turnover	4.86	3.42	2.61
Inventory Turnover	0.00	0.00	0.00
Fixed Asset Turnover	25.92	32.78	38.88
Accounts Payable Turnover	14.66	20.72	16.73
Days Sales Outstanding (DSO)	75.14	106.72	140.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Payable Outstanding (DPO)	24.90	17.62	21.82
Cash Conversion Cycle (CCC)	50.25	89.10	118.18
Capital & Investment Metrics	-	-	-
Invested Capital	123	271	256
Invested Capital Turnover	5.01	3.17	2.34
Increase / (Decrease) in Invested Capital	70	148	-15
Enterprise Value (EV)	577	551	368
Market Capitalization	727	581	433
Book Value per Share	$2.66	$2.90	$3.14
Tangible Book Value per Share	$2.06	$2.07	$2.43
Total Capital	281	330	345
Total Debt	1.90	25	30
Total Long-Term Debt	1.24	0.04	0.01
Net Debt	-156	-34	-59
Capital Expenditures (CapEx)	3.20	6.84	3.56
Debt-free, Cash-free Net Working Capital (DFCFNWC)	14	134	123
Debt-free Net Working Capital (DFNWC)	172	194	213
Net Working Capital (NWC)	171	169	183
Net Nonoperating Expense (NNE)	-1.28	-0.76	0.45
Net Nonoperating Obligations (NNO)	-156	-34	-59
Total Depreciation and Amortization (D&A)	11	16	16
Debt-free, Cash-free Net Working Capital to Revenue	3.24%	21.54%	20.02%
Debt-free Net Working Capital to Revenue	38.95%	31.04%	34.50%
Net Working Capital to Revenue	38.80%	27.03%	29.63%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	$0.34	$0.07	$0.20
Adjusted Weighted Average Basic Shares Outstanding	101.23M	103.51M	102.40M
Adjusted Diluted Earnings per Share	$0.34	$0.06	$0.18
Adjusted Weighted Average Diluted Shares Outstanding	102.98M	105.62M	109.42M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	102.51M	104.17M	101.98M
Normalized Net Operating Profit after Tax (NOPAT)	21	17	32
Normalized NOPAT Margin	4.86%	2.78%	5.20%
Pre Tax Income Margin	5.17%	2.61%	4.50%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	23.52%
Augmented Payout Ratio	12.20%	0.00%	126.48%

This table displays calculated financial ratios and metrics derived from DocGo's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	21.53%	-10.10%	-4.15%	14.58%	78.83%	83.16%	69.98%	31.45%	-25.66%	-39.35%
EBITDA Growth	54.17%	-96.07%	-125.29%	-68.69%	142.73%	1,835.08%	758.07%	226.93%	4.21%	-115.57%
EBIT Growth	60.66%	-111.85%	-167.21%	-95.35%	264.88%	601.01%	339.86%	1,720.52%	8.04%	-148.61%
NOPAT Growth	316.95%	-99.64%	-150.11%	-70.49%	21.94%	13,542.14%	321.58%	190.14%	15.84%	-168.38%
Net Income Growth	207.71%	-64.74%	-141.81%	-88.57%	87.73%	11.82%	370.58%	336.03%	-1.83%	-195.67%
EPS Growth	-25.00%	-99.40%	-133.33%	-118.18%	66.67%	-45.45%	433.33%	400.00%	0.00%	-150.00%
Operating Cash Flow Growth	-7.22%	0.71%	-226.57%	-10.31%	-718.26%	32.26%	53.98%	246.54%	167.64%	317.73%
Free Cash Flow Firm Growth	0.00%	0.00%	-338.12%	-365.28%	-7,785.17%	-100.64%	29.08%	39.78%	95.88%	106.96%
Invested Capital Growth	5.29%	132.49%	253.87%	233.72%	135.80%	120.48%	58.25%	44.70%	4.31%	-5.54%
Revenue Q/Q Growth	-4.75%	4.28%	3.88%	11.05%	48.66%	6.80%	-3.59%	-14.13%	-15.92%	-12.87%
EBITDA Q/Q Growth	-61.08%	-84.04%	-181.56%	241.87%	201.76%	27.22%	20.83%	-29.52%	-3.81%	-119.01%
EBIT Q/Q Growth	-79.62%	-200.02%	-1,502.86%	108.26%	1,498.18%	37.34%	32.22%	-37.27%	-5.15%	-161.79%
NOPAT Q/Q Growth	-50.26%	-98.45%	-8,715.74%	144.33%	105.57%	73.75%	39.94%	-41.95%	-17.93%	-202.56%
Net Income Q/Q Growth	-79.02%	189.82%	-154.82%	134.29%	244.61%	72.63%	32.65%	-44.75%	-22.41%	-268.23%
EPS Q/Q Growth	-72.73%	266.67%	-127.27%	33.33%	350.00%	20.00%	66.67%	-40.00%	-16.67%	-160.00%
Operating Cash Flow Q/Q Growth	-37.76%	-217.75%	-164.58%	146.25%	-529.04%	87.10%	-79.76%	448.28%	-16.25%	-58.47%
Free Cash Flow Firm Q/Q Growth	-103.56%	-3,790.53%	-103.46%	5.84%	-5.80%	1.00%	27.79%	20.06%	92.77%	267.29%
Invested Capital Q/Q Growth	84.78%	14.13%	56.01%	1.43%	30.56%	6.71%	12.21%	-7.25%	-5.89%	-3.36%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	31.70%	38.98%	100.00%	100.00%	29.51%	-49.26%	35.03%	100.00%	100.00%	-130.21%
EBITDA Margin	5.23%	0.80%	-2.74%	3.50%	7.10%	8.46%	10.60%	8.70%	9.95%	-2.17%
Operating Margin	4.03%	0.07%	-6.11%	1.26%	4.67%	5.86%	8.26%	6.15%	7.31%	-6.18%
EBIT Margin	2.34%	-2.24%	-5.97%	0.44%	4.77%	6.14%	8.42%	6.15%	6.94%	-4.92%
Profit (Net Income) Margin	2.36%	6.57%	-3.47%	1.07%	2.48%	4.01%	5.52%	3.55%	3.28%	-6.33%
Tax Burden Percent	85.99%	-361.64%	64.79%	135.92%	50.57%	65.54%	67.44%	61.23%	50.31%	116.30%
Interest Burden Percent	117.52%	80.97%	89.71%	177.40%	102.82%	99.71%	97.21%	94.31%	93.89%	110.58%
Effective Tax Rate	14.01%	0.00%	0.00%	-35.92%	49.44%	34.46%	32.56%	38.77%	49.69%	0.00%
Return on Invested Capital (ROIC)	14.93%	0.26%	-15.15%	6.10%	6.97%	12.17%	15.84%	11.76%	9.85%	-10.13%
ROIC Less NNEP Spread (ROIC-NNEP)	16.33%	-4.04%	-15.81%	6.66%	6.74%	11.81%	16.03%	12.33%	10.99%	-4.96%
Return on Net Nonoperating Assets (RNNOA)	-7.14%	2.63%	8.39%	-3.53%	-2.41%	-3.85%	-2.78%	-2.58%	-1.74%	0.75%
Return on Equity (ROE)	7.79%	2.89%	-6.76%	2.57%	4.56%	8.33%	13.06%	9.18%	8.11%	-9.38%
Cash Return on Invested Capital (CROIC)	0.00%	-46.17%	-101.95%	-108.35%	-72.57%	-70.47%	-35.25%	-24.38%	7.28%	10.94%
Operating Return on Assets (OROA)	4.50%	-2.81%	-7.09%	0.56%	6.57%	8.67%	13.19%	10.40%	10.55%	-6.41%
Return on Assets (ROA)	4.54%	8.24%	-4.12%	1.34%	3.42%	5.67%	8.65%	6.01%	4.99%	-8.25%
Return on Common Equity (ROCE)	5.25%	2.82%	-6.58%	2.51%	4.48%	8.18%	12.86%	9.08%	8.06%	-9.41%
Return on Equity Simple (ROE_SIMPLE)	16.60%	0.00%	6.26%	2.52%	3.20%	0.00%	7.89%	9.23%	8.92%	0.00%
Net Operating Profit after Tax (NOPAT)	3.61	0.06	-4.83	2.14	4.40	7.65	11	6.21	5.10	-5.23
NOPAT Margin	3.46%	0.05%	-4.28%	1.71%	2.36%	3.84%	5.57%	3.77%	3.68%	-4.33%
Net Nonoperating Expense Percent (NNEP)	-1.40%	4.30%	0.66%	-0.56%	0.23%	0.36%	-0.20%	-0.57%	-1.14%	-5.17%
Return On Investment Capital (ROIC_SIMPLE)	-	0.02%	-	-	-	2.32%	-	-	-	-1.52%
Cost of Revenue to Revenue	68.30%	61.02%	0.00%	0.00%	70.49%	149.26%	64.98%	0.00%	0.00%	230.21%
SG&A Expenses to Revenue	21.27%	30.08%	25.86%	24.54%	18.02%	21.84%	20.92%	21.07%	20.76%	29.00%
R&D to Revenue	1.32%	1.58%	1.65%	2.05%	1.73%	1.60%	1.24%	1.44%	2.27%	3.05%
Operating Expenses to Revenue	27.67%	38.91%	106.11%	98.74%	24.84%	-55.12%	26.84%	93.85%	92.69%	-124.15%
Earnings before Interest and Taxes (EBIT)	2.44	-2.44	-6.74	0.56	8.91	12	16	10	9.62	-5.95
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	5.46	0.87	-3.09	4.39	13	17	20	14	14	-2.62
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.79	2.66	3.18	3.47	1.92	1.93	1.35	1.00	1.04	1.35
Price to Tangible Book Value (P/TBV)	4.79	3.44	4.62	5.00	2.75	2.69	1.85	1.35	1.40	1.75
Price to Revenue (P/Rev)	2.21	1.65	2.04	2.15	1.04	0.93	0.60	0.42	0.49	0.70
Price to Earnings (P/E)	20.01	21.02	43.28	168.85	75.23	84.68	19.48	10.43	11.02	21.64
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	5.00%	4.76%	2.31%	0.59%	1.33%	1.18%	5.13%	9.59%	9.07%	4.62%
Enterprise Value to Invested Capital (EV/IC)	7.85	4.69	4.03	4.55	2.05	2.03	1.36	1.00	1.05	1.44
Enterprise Value to Revenue (EV/Rev)	1.87	1.31	1.78	1.96	0.97	0.88	0.59	0.38	0.40	0.60
Enterprise Value to EBITDA (EV/EBITDA)	15.70	17.70	38.34	83.87	28.34	17.55	7.51	4.32	4.27	8.02
Enterprise Value to EBIT (EV/EBIT)	18.77	26.20	94.79	0.00	162.27	36.85	10.88	5.90	5.80	12.26
Enterprise Value to NOPAT (EV/NOPAT)	23.33	19.57	63.43	0.00	34.58	59.34	16.86	9.68	9.37	26.62
Enterprise Value to Operating Cash Flow (EV/OCF)	29.36	19.97	0.00	0.00	0.00	0.00	0.00	0.00	5.42	5.23
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	14.79	12.76
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.03	0.01	0.01	0.07	0.05	0.08	0.10	0.09	0.09	0.10
Long-Term Debt to Equity	0.01	0.00	0.00	0.01	0.01	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.44	-0.65	-0.53	-0.53	-0.36	-0.33	-0.17	-0.21	-0.16	-0.15
Leverage Ratio	1.26	1.39	1.40	1.34	1.38	1.51	1.50	1.46	1.48	1.53
Compound Leverage Factor	1.48	1.12	1.25	2.38	1.42	1.51	1.46	1.38	1.39	1.69
Debt to Total Capital	2.58%	0.68%	0.67%	6.64%	5.12%	7.59%	8.71%	8.63%	8.47%	8.70%
Short-Term Debt to Total Capital	2.05%	0.24%	0.23%	6.12%	4.46%	7.58%	8.70%	8.63%	8.46%	8.69%
Long-Term Debt to Total Capital	0.52%	0.44%	0.45%	0.52%	0.67%	0.01%	0.01%	0.01%	0.01%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	2.38%	2.03%	1.83%	1.34%	1.29%	1.33%	1.09%	0.81%	-0.09%	-1.66%
Common Equity to Total Capital	95.04%	97.29%	97.49%	92.02%	93.59%	91.08%	90.20%	90.55%	91.62%	92.97%
Debt to EBITDA	0.13	0.06	0.10	1.91	0.86	0.80	0.55	0.46	0.46	0.65
Net Debt to EBITDA	-3.03	-4.79	-5.88	-8.48	-2.05	-1.09	-0.21	-0.56	-0.92	-1.29
Long-Term Debt to EBITDA	0.03	0.04	0.06	0.15	0.11	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.20	0.06	0.16	-27.52	1.05	2.70	1.23	1.04	1.01	2.17
Net Debt to NOPAT	-4.50	-5.30	-9.73	121.91	-2.50	-3.69	-0.48	-1.26	-2.01	-4.29
Long-Term Debt to NOPAT	0.04	0.04	0.10	-2.16	0.14	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	8.83	5.33	5.65	6.95	4.27	3.59	3.38	3.12	3.12	3.64
Noncontrolling Interest Sharing Ratio	32.59%	2.60%	2.58%	2.12%	1.88%	1.72%	1.50%	1.15%	0.59%	-0.22%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.54	2.71	2.37	2.56	2.36	1.99	2.09	2.13	2.19	2.50
Quick Ratio	3.51	2.60	2.31	2.48	2.30	1.89	2.03	2.10	2.15	2.46
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-1.80	-70	-142	-134	-142	-140	-101	-81	-5.84	9.77
Operating Cash Flow to CapEx	705.04%	-727.49%	-1,243.80%	751.05%	-5,704.99%	-215.16%	-1,148.13%	3,235.64%	4,495.30%	1,616.12%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	-273.66	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	-28.83	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	-31.34	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.92	1.25	1.19	1.25	1.38	1.41	1.57	1.69	1.52	1.30
Accounts Receivable Turnover	0.00	4.86	4.19	4.73	3.72	3.42	3.39	3.95	3.15	2.61
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	25.92	25.36	26.43	27.08	32.78	36.98	39.16	37.43	38.88
Accounts Payable Turnover	26.36	14.66	11.69	13.56	12.80	20.72	24.80	29.54	19.15	16.73
Days Sales Outstanding (DSO)	0.00	75.14	87.04	77.09	98.23	106.72	107.61	92.38	115.82	140.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	13.85	24.90	31.23	26.92	28.51	17.62	14.72	12.36	19.06	21.82
Cash Conversion Cycle (CCC)	-13.85	50.25	55.81	50.17	69.72	89.10	92.89	80.02	96.76	118.18
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	108	123	192	194	254	271	303	281	265	256
Invested Capital Turnover	4.31	5.01	3.54	3.57	2.95	3.17	2.84	3.12	2.68	2.34
Increase / (Decrease) in Invested Capital	5.41	70	138	136	146	148	112	87	11	-15
Enterprise Value (EV)	846	577	773	884	519	551	412	280	279	368
Market Capitalization	1,002	727	887	970	553	581	420	314	340	433
Book Value per Share	$2.62	$2.66	$2.72	$2.70	$2.77	$2.90	$3.00	$3.10	$3.18	$3.14
Tangible Book Value per Share	$2.07	$2.06	$1.87	$1.87	$1.94	$2.07	$2.19	$2.28	$2.37	$2.43
Total Capital	278	281	286	304	307	330	345	348	355	345
Total Debt	7.16	1.90	1.92	20	16	25	30	30	30	30
Total Long-Term Debt	1.46	1.24	1.27	1.58	2.04	0.04	0.03	0.03	0.02	0.01
Net Debt	-163	-156	-119	-89	-38	-34	-12	-37	-60	-59
Capital Expenditures (CapEx)	1.05	1.20	1.86	1.42	0.80	2.75	0.93	1.15	0.69	0.80
Debt-free, Cash-free Net Working Capital (DFCFNWC)	17	14	30	52	115	134	164	139	119	123
Debt-free Net Working Capital (DFNWC)	187	172	150	161	168	194	205	205	208	213
Net Working Capital (NWC)	181	171	149	143	154	169	175	175	178	183
Net Nonoperating Expense (NNE)	1.14	-7.09	-0.91	0.80	-0.23	-0.34	0.10	0.36	0.55	2.42
Net Nonoperating Obligations (NNO)	-163	-156	-92	-89	-38	-34	-12	-37	-60	-59
Total Depreciation and Amortization (D&A)	3.01	3.31	3.65	3.83	4.34	4.62	4.18	4.20	4.18	3.32
Debt-free, Cash-free Net Working Capital to Revenue	3.75%	3.24%	6.89%	11.54%	21.52%	21.54%	23.28%	18.65%	17.07%	20.02%
Debt-free Net Working Capital to Revenue	41.21%	38.95%	34.45%	35.71%	31.43%	31.04%	29.15%	27.55%	29.95%	34.50%
Net Working Capital to Revenue	39.95%	38.80%	34.30%	31.60%	28.86%	27.03%	24.88%	23.50%	25.63%	29.63%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.03	$0.07	($0.03)	($0.02)	$0.05	$0.07	$0.11	$0.06	$0.05	($0.02)
Adjusted Weighted Average Basic Shares Outstanding	98.96M	101.23M	102.58M	103.59M	103.87M	103.51M	103.82M	101.84M	102.07M	102.40M
Adjusted Diluted Earnings per Share	$0.03	$0.11	($0.03)	($0.02)	$0.05	$0.06	$0.10	$0.06	$0.05	($0.03)
Adjusted Weighted Average Diluted Shares Outstanding	107.40M	102.98M	102.58M	103.59M	104.99M	105.62M	108.51M	106.32M	106.29M	109.42M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	102.83M	102.51M	103.47M	103.79M	103.90M	104.17M	101.57M	102.32M	102.05M	101.98M
Normalized Net Operating Profit after Tax (NOPAT)	5.50	1.58	-2.28	2.79	6.20	9.94	14	8.67	6.76	-1.36
Normalized NOPAT Margin	5.28%	1.45%	-2.02%	2.22%	3.32%	4.99%	7.09%	5.26%	4.87%	-1.13%
Pre Tax Income Margin	2.75%	-1.82%	-5.35%	0.79%	4.91%	6.12%	8.19%	5.80%	6.51%	-5.44%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	43.83	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	29.01	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	41.32	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	26.50	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	23.52%
Augmented Payout Ratio	1.18%	12.20%	21.38%	45.94%	35.14%	0.00%	19.85%	33.63%	38.20%	126.48%

Financials Breakdown Chart

Key Financial Trends

DocGo Inc. (NASDAQ: DCGO) has shown significant volatility in its financial performance over the past two years, with notable swings in revenue, profitability, and cash flow metrics.

Positive Trends:

Improvement in Operating Revenue from $104.3 million in Q3 2022 to $192.1 million in Q1 2024, representing strong growth in top-line sales over the last 6 quarters.
Positive Net Income in several quarters, including $10.6 million in Q1 2024 and $7.99 million in Q4 2023, showing the company can generate profits intermittently.
Increase in Total Assets from $355.9 million in Q3 2022 to $493.9 million in Q3 2024, suggesting asset base expansion to support operations and growth.
Healthy cash flow from operations in positive quarters, such as $37.1 million in Q2 2024 and $31.3 million in Q3 2024, supporting liquidity and operational funding without relying on financing.
Goodwill and intangible assets have increased, showing acquisition or organic growth investing in long-term value drivers.

Neutral Observations:

Consistent investments in property, plant & equipment with quarterly capex in the range of $0.7 million to $1.2 million, indicating steady maintenance or expansion.
Share count has been relatively stable near 100 million shares outstanding, which maintains shareholder base dilution risk at a minimum.
Repayment of debt and issuance activities fluctuate, with significant repayments in Q1 2024 balanced by new debt issued in prior quarters, showing active debt management.
Fluctuations in marketing and R&D expenses each quarter, indicating adjustments in investment levels aligned to growth strategies.
Cash interest paid varies but overall remains moderate relative to debt levels, suggesting manageable interest expenses.

Negative Trends:

Negative gross profit in Q4 2024 at -$157 million driven by Total Cost of Revenue exceeding revenues, indicating operational inefficiency or one-time charges.
Net loss of $7.65 million in Q4 2024, a sharp reversal from positive income in previous quarters, signaling operational or market challenges.
Operating Expense spikes, notably high "Other Operating Expenses" in several quarters (e.g., $109 million in Q2 2024, $88 million in Q3 2024), which heavily impact profitability.
Large fluctuations and sometimes negative total operating income, such as a loss of $7.47 million in Q4 2024, compared to prior profitable quarters.
Cash flow from operations turned negative in Q4 2023 and Q1 2024, with significant swings leading to cash burn in some periods (-$10.6 million in Q1 2024), which could stress liquidity.

Summary: DocGo experienced strong revenue growth over the last two years, supported by asset growth and occasionally generating profits and positive operational cash flow. However, the recent Q4 2024 quarter marks a setback with large losses at the gross profit and net income levels, driven by surging costs and expenses. Investors should watch closely for management’s efforts to control costs and restore profitability while leveraging their expanding asset base and operating cash flow trends.

10/25/25 06:11 PM ETAI Generated. May Contain Errors.

Frequently Asked Questions About DocGo's Financials

When does DocGo's financial year end?

According to the most recent income statement we have on file, DocGo's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has DocGo's net income changed over the last 2 years?

DocGo's net income appears to be on a downward trend, with a most recent value of $13.36 million in 2024, falling from $30.74 million in 2022. The previous period was $10.05 million in 2023. See where experts think DocGo is headed by visiting DocGo's forecast page.

What is DocGo's operating income?

DocGo's total operating income in 2024 was $28.69 million, based on the following breakdown:

Total Gross Profit: $213.57 million
Total Operating Expenses: $184.89 million

How has DocGo's revenue changed over the last 2 years?

Over the last 2 years, DocGo's total revenue changed from $440.52 million in 2022 to $616.56 million in 2024, a change of 40.0%.

How much debt does DocGo have?

DocGo's total liabilities were at $140.44 million at the end of 2024, a 24.2% decrease from 2023, and a 22.8% increase since 2022.

How much cash does DocGo have?

In the past 2 years, DocGo's cash and equivalents has ranged from $59.29 million in 2023 to $157.34 million in 2022, and is currently $89.24 million as of their latest financial filing in 2024.

How has DocGo's book value per share changed over the last 2 years?

Over the last 2 years, DocGo's book value per share changed from 2.66 in 2022 to 3.14 in 2024, a change of 18.3%.

Related Companies

This page (NASDAQ:DCGO) was last updated on 10/25/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

DocGo (DCGO) Financials

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About DocGo's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

DocGo (DCGO) Financials

Annual Income Statements for DocGo

Quarterly Income Statements for DocGo

Annual Cash Flow Statements for DocGo

Quarterly Cash Flow Statements for DocGo

Annual Balance Sheets for DocGo

Quarterly Balance Sheets for DocGo

Annual Metrics And Ratios for DocGo

Quarterly Metrics And Ratios for DocGo

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About DocGo's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools